New compound prevents alcoholic behavior, relapse in rats

A study of alcohol-dependent animals shows that a newly discovered compound that blocks chemical signals active during the brain’s response to stress effectively stops excessive drinking and prevents relapse.

The new, synthetic compound, known as MTIP, also muted the anxiety that typically develops in rats experiencing the equivalent of a hangover. Such stress is linked with higher levels of a brain chemical called corticotropin-releasing factor (CRF), which is also thought to trigger relapse in rats that have developed a long-term dependency on alcohol. The research, by Markus Heilig, MD, PhD, at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), and his team, appears in the March 7 issue of The Journal of Neuroscience.

“This study shows the activity of a compound that potentially could be used in human subjects,” says George Koob, PhD, of the Scripps Research Institute. “It moves the field over another translational barrier, closer to the day when the dark side of addiction is treated.”

The new findings build on previous work showing the effectiveness of blocking certain CRF receptors—proteins that bind CRF and make it active—in treating alcohol dependence in animals. CRF levels in the brain rise in the short term after drinking; in subjects that are not dependent, this activation returns to normal within a day or so. The new study shows that the CRF system becomes overactive in the long term in animals with a history of alcohol dependence, increasing the risk for relapse.

Heilig and his team showed that MTIP blocked the activity of CRF in stressful situations without affecting its activity under ordinary circumstances. They studied rats that had been put through several cycles of heavy alcohol consumption and withdrawal to create dependency, as well as animals selectively bred to consume more alcohol. Injections of MTIP prevented excessive drinking of alcohol in both cases and eliminated the rats’ susceptibility to relapse under stress. Yet the compound did not affect their native curiosity or lower levels of drinking alcohol in rats that were not alcohol-dependent.

In addition to alcoholism, the compound may prove to be useful in the treatment of depression or anxiety disorders, in which CRF levels can be especially high.

The compound or similar molecules can be given orally, reach the brain in sufficient amounts to block more than 90 percent of certain brain CRF receptors, and do not accumulate in other organs, most importantly the liver, in ways that would cause concerns about potential side effects, says Heilig.

From Society for Neuroscience

1 COMMENT

  1. This is really good news for physical withdrawel treatment. What I saw past physical withdrawel in my bf was a man terrified because he had no idea how to live without the comfort of his drink. The severe disorientation with basic emotions, life challenges, it was extreme fear of existance. He’s relapsed. That’s because it’s more then physical problems alcoholics deal with. Repressed emotions, coping skill that’s lacking…they are extremely unstable. Like ADD x a bazillion. They are adrenaline junkies, create chaos when there is none because they are into extremes – drinking an 18 pack, a fifth, getting high, and talking to you like they drank a few not that much. Target the chemistry that seeks super highs all the time – cuz that’s why they seek the super low of alcohol.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.